Glutathione-responsive and -exhausting metal nanomedicines for robust synergistic cancer therapy
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Due to their rapid and uncontrolled proliferation, cancer cells are characterized by overexpression of glutathione (GSH), which impairs reactive oxygen species (ROS)-based therapy and weakens the chemotherapeutic agent-induced toxification. Extensive efforts have been made in the past few years to improve therapeutic outcomes by depleting intracellular GSH. Special focus has been given to the anticancer applications of varieties of metal nanomedicines with GSH responsiveness and exhaustion capacity. In this review, we introduce several GSH-responsive and -exhausting metal nanomedicines that can specifically ablate tumors based on the high concentration of intracellular GSH in cancer cells. These include inorganic nanomaterials, metal-organic frameworks (MOFs), and platinum-based nanomaterials. We then discuss in detail the metal nanomedicines that have been extensively applied in synergistic cancer therapy, including chemotherapy, photodynamic therapy (PDT), sonodynamic therapy (SDT), chemodynamic therapy (CDT), ferroptotic therapy, and radiotherapy. Finally, we present the horizons and challenges in the field for future development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
Stockwell, B. R. (2022) · Cell · doi:10.1016/j.cell.2022.06.003 · Cited by 3,056 · cited 1×
“Concretely, GPX4 uses GSH as the substrate to reduce phospholipid hydroperoxides (PLOOHs) to hydroxyl derivatives (PLOHs), and oxidizes GSH to GSSH, therefore alleviating the damage of oxidative stress to tumor cells (Stockwell, 2022).”
BackgroundBroadening horizons: the role of ferroptosis in cancer
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00462-0 · Cited by 2,897 · cited 1×
“Researchers have revealed that the morphological characteristics of ferroptosis are the diminishment of mitochondrial volume, the augmentation of membrane density, and the disappearance of mitochondria (Chen et al., 2021).”
BackgroundGlutathione: overview of its protective roles, measurement, and biosynthesis
Forman, H. J., Zhang, H., & Rinna, A. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.006 · Cited by 2,636 · cited 1×
“For example, in order to maintain intracellular redox homeostasis and build a powerful antioxidant defense, cancer cells are typically characterized by high level of antioxidants, especially GSH with a high concentration of ~10 mM, which is approximately ten times higher than that in normal cells (Forman et al., 2009).”
BackgroundJohnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485 · cited 1×
“However, their therapeutic outcomes are limited because of drug resistance due to the intracellular inactivation effect (Johnstone et al., 2016).”
BackgroundReactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443 · cited 1×
“Nanotechnology especially has a prominent position in the area of biomedicine, and nanomedicines are being widely explored for the detection, diagnosis, and treatment of cancer (Yang et al., 2019; Huo et al., 2020).”
BackgroundNanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791 · cited 1×
“In the last few years, various GSH modulation-enhanced combinational therapy strategies have been extensively exploited, accompanied by the development of versatile metal-based nanosystems with different structures, functionalities, and treatment performances (Fan et al., 2017).”
BackgroundCisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751 · cited 1×
“As a chemotherapeutic agent, platinum is one of the most widely used metal-based anticancer components (Ghosh, 2019).”
BackgroundMolecular mechanisms of resistance and toxicity associated with platinating agents
Rabik, C. A., & Dolan, M. E. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.09.006 · Cited by 1,564
Lin, L., Song, J., Song, L., Ke, K., Liu, Y., Zhou, Z., Shen, Z., Li, J., Yang, Z., Tang, W., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712027 · Cited by 1,466 · cited 2×
“A typical example is to develop an MnO2-based nanocarrier for chemotherapeutics delivery, which could degrade and release drugs in response to overexpressed GSH (Lin et al., 2018).”
BackgroundSingle-Atom Catalysts across the Periodic Table
Kaiser, S. K., Chen, Z., Faust Akl, D., Mitchell, S., & Pérez-Ramírez, J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00576 · Cited by 1,367 · cited 1×
“It is interesting that some single-atom metal nanozymes showed stronger GSH peroxidase catalytic activity owing to their large portion of superficial active-site atoms and high atomic utilization efficiency (Kaiser et al., 2020).”
BackgroundNiu, B., Liao, K., Zhou, Y., Wen, T., Quan, G., Pan, X., & Wu, C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121110 · Cited by 1,168 · cited 1×
“As intracellular GSH is exhausted, the GSH synthesis system will be activated accordingly, which would weaken the efficacy of GSH exhaustion-based cancer therapies in long-term treatment (Niu et al., 2021).”
BackgroundHarris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.019 · Cited by 993 · cited 1×
“For instance, GSH, composed of cysteine, glycine, and glutamic acid, accounts for the majority of cellular antioxidants to create highly reductive TME and is involved in tumor initiation, progression, and metastasis (Harris et al., 2015; Estrela et al., 2016).”
BackgroundFu, L., Wan, Y., Qi, C., He, J., Li, C., Yang, C., Xu, H., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202006892 · Cited by 820 · cited 1×
“(GOx), and the chemotherapeutic drug doxorubicin (DOX) PGC-DOX for efficient cancer therapy (Fu et al., 2021).”
BackgroundEngineering nanomedicine for glutathione depletion-augmented cancer therapy
Xiong, Y., Xiao, C., Li, Z., & Yang, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00718h · Cited by 692 · cited 1×
“Upstream cysteine supply block, NADPH control, glutathione reductase activity repression, GSH efflux pumps stimulation, and so on have proven to be feasible approaches to ablate tumors (Xiong et al., 2021).”
BackgroundSingle‐Atom Pd Nanozyme for Ferroptosis‐Boosted Mild‐Temperature Photothermal Therapy
Chang, M., Hou, Z., Wang, M., Yang, C., Wang, R., Li, F., Liu, D., Peng, T., Li, C., & Lin, J. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202101924 · Cited by 682 · cited 1×
“Lin and coworkers rationally designed a single-atom Pd nanozyme (Pd SAzyme) with atom-economical utilization of catalytic centers (Figure 1A); (Chang et al., 2021) the Pd SAzyme displayed Michaelis-Menton kinetics during the catalytic reaction of GSH (Figures 1B, C).”
MethodLiu, C., Wang, D., Zhang, S., Cheng, Y., Yang, F., Xing, Y., Xu, T., Dong, H., & Zhang, X. (2019) · ACS Nano · doi:10.1021/acsnano.8b09387 · Cited by 641 · cited 2×
“…copper/manganese silicate nanospheres (mCMSNs) to achieve GSH-eliminated synergistic therapy, where in situ GSH in tumor triggered mCMSNs biodegradation and reduced Cu2+ into Cu+ for enhanced hydroxyl radical production, leading to a powerful inhibition effect on tumors (Liu et al., 2019).”
BackgroundCisplatin resistance and opportunities for precision medicine
Amable, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.001 · Cited by 589 · cited 1×
“The main mechanism of platinum drugs is to hamper the replication and transcription of DNA by forming covalent adducts between platinum complexes and subcellular compounds like DNA, RNA, and other proteins (Amable, 2016).”
BackgroundGSH‐Depleted PtCu3 Nanocages for Chemodynamic‐ Enhanced Sonodynamic Cancer Therapy
Zhong, X., Wang, X., Cheng, L., Tang, Y., Zhan, G., Gong, F., Zhang, R., Hu, J., Liu, Z., & Yang, X. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201907954 · Cited by 541 · cited 1×
“designed PtCu3-PEG nanocages, which can serve as horseradish peroxidase-like and GSH peroxidase-like nanozymes for enhanced ROS-based therapy by exhaustion of GSH (Zhong et al., 2020).”
BackgroundGong, F., Cheng, L., Yang, N., Betzer, O., Feng, L., Zhou, Q., Li, Y., Chen, R., Popovtzer, R., & Liu, Z. (2019) · Advanced Materials · doi:10.1002/adma.201900730 · Cited by 533 · cited 1×
“designed a US-triggered MnWOX nanosystem modified with PEG (termedMnWOX-PEG) to endow the capability of GSH-enhanced ROS ((1)O2 and •OH) production for killing malignant tumors (Figure 6D) (Gong et al., 2019).”
BackgroundManganese Oxide Nanomaterials: Synthesis, Properties, and Theranostic Applications
Ding, B., Zheng, P., Ma, P., & Lin, J. (2020) · Advanced Materials · doi:10.1002/adma.201905823 · Cited by 521 · cited 1×
“In addition, manganese oxide nanomaterials (MONs), including MnO2, Mn2O3, and Mn3O4, possess a similar GSH elimination property to Cu-based nanomaterials, and react with GSH along with the decomposition of MnOx into Mn 2+ for initiation of the Fenton-like reaction (Ding et al., 2020; Qian et al., 2020).”
BackgroundInorganic nanomaterials with rapid clearance for biomedical applications
Wang, X., Zhong, X., Li, J., Liu, Z., & Cheng, L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00461h · Cited by 509
Makovec, T. (2019) · Radiology and Oncology · doi:10.2478/raon-2019-0018 · Cited by 480 · cited 2×
“The mechanisms are multifactorial such as the function of nucleotide excision repair pathway, decreased intake as well as increased efflux of platinum drugs, and, medicine inactivation associated with GSH or metallothioneins, which is the most crucial reason for high-level drug resistance (Makovec, 2019).”
BackgroundStrategies for optimizing the response of cancer and normal tissues to radiation
Moding, E. J., Kastan, M. B., & Kirsch, D. G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4003 · Cited by 461
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Peng, S., Xiao, F., Chen, M., & Gao, H. (2022) · Advanced Science · doi:10.1002/advs.202103836 · Cited by 441 · cited 1×
“This stimuli-responsive behavior can be used for selective drug delivery into tumor tissue or cancer cells, thereby improving therapeutic efficiency and reducing side effects (Zhou et al., 2018; Peng et al., 2022).”
BackgroundLi, F.-J., Long, H.-Z., Zhou, Z.-W., Luo, H.-Y., Xu, S.-G., & Gao, L.-C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.910292 · Cited by 438
Emerging Strategies of Nanomaterial‐Mediated Tumor Radiosensitization
Xie, J., Gong, L., Zhu, S., Yong, Y., Gu, Z., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201802244 · Cited by 415 · cited 1×
“Nevertheless, as an effective antioxidant, the overexpression of GSH in tumor cells is one of the typical reasons for reducing free radicals, and consequently contributing to radiation resistance (Xie et al., 2019).”
BackgroundWang, C., Cao, F., Ruan, Y., Jia, X., Zhen, W., & Jiang, X. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201903981 · Cited by 411
Glutathione-Depleting Nanomedicines for Synergistic Cancer Therapy
Cheng, X., Xu, H.-D., Ran, H.-H., Liang, G., & Wu, F.-G. (2021) · ACS Nano · doi:10.1021/acsnano.1c00498 · Cited by 374
Nanocatalytic Tumor Therapy by Single-Atom Catalysts
Huo, M., Wang, L., Wang, Y., Chen, Y., & Shi, J. (2019) · ACS Nano · doi:10.1021/acsnano.9b00457 · Cited by 368 · cited 1×
“As an example, Liu and co-workers designed a Fe-contained and PEG-modified nanocatalyst reacting with overexpressed H2O2 to generate sufficient •OH, which is able to kill tumor cells (Huo et al., 2019).”
BackgroundMeng, X., Deng, J., Liu, F., Guo, T., Liu, M., Dai, P., Fan, A., Wang, Z., & Zhao, Y. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02904 · Cited by 338 · cited 1×
“synthesized a kind of MOFs using Zn and disulfide-containing imidazole for Ce6 delivery (Meng et al., 2019).”
MethodSelf-citation2D Piezoelectric Bi2MoO6 Nanoribbons for GSH‐Enhanced Sonodynamic Therapy
Dong, Y., Dong, S., Liu, B., Yu, C., Liu, J., Yang, D., Yang, P., & Lin, J. (2021) · Advanced Materials · doi:10.1002/adma.202106838 · Cited by 337 · cited 2×
“utilized PEG-modified Bi2MoO6 to design nanoribbons, named Bi2MoO6-PEG NRs (BMO NRs), for GSH-enhanced SDT (Dong et al., 2021).”
BackgroundMethodYang, N., Xiao, W., Song, X., Wang, W., & Dong, X. (2020) · Nano-Micro Letters · doi:10.1007/s40820-019-0347-0 · Cited by 324 · cited 1×
“In particular, GSH can effectively scavenge ROS and maintain intracellular reductive homeostasis, further promoting the occurrence and development of tumor (Yang et al., 2020; Yang et al., 2022b).”
BackgroundA Mn(III)-Sealed Metal–Organic Framework Nanosystem for Redox-Unlocked Tumor Theranostics
Wan, S.-S., Cheng, Q., Zeng, X., & Zhang, X.-Z. (2019) · ACS Nano · doi:10.1021/acsnano.9b00300 · Cited by 322 · cited 4×
“reported a MOF nanosystem based on coordination between TCPP and Mn for selective tumor damage by redox-unlocked effect (Figure 2D) (Wan et al., 2019).”
BackgroundMethodInfluentialXu, Q., Zhan, G., Zhang, Z., Yong, T., Yang, X., & Gan, L. (2021) · Theranostics · doi:10.7150/thno.45511 · Cited by 309 · cited 1×
“introduced Zr into a manganese porphyrin-based MOF (Mn-MOF) to construct a biocompatible nanosensitizer along with the capacity of GSH exhaustion-enhanced ferroptosis (Figure 5F) (Xu et al., 2021).”
BackgroundMetal nanoparticles: a theranostic nanotool against cancer
Sharma, H., Mishra, P. K., Talegaonkar, S., & Vaidya, B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.009 · Cited by 294 · cited 1×
“Owing to their unique physicochemical and functional properties, metal nanomedicines display enormous potential in a variety of anticancer applications, such as selective drug delivery, tumor microenvironment (TME) regulation, and combination therapy against cancer (Sharma et al., 2015; Hu et al., 2022; Pena et al., 2…”
BackgroundYin, S., Song, G., Yang, Y., Zhao, Y., Wang, P., Zhu, L., Yin, X., & Zhang, X. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201901417 · Cited by 279 · cited 2×
“In this process, the nanozyme can catalyze GSH into glutathione disulfide (GSSG) by oxidation of H2O2, realizing tumor-specific catalytic therapy with response to the TME featuring overexpressed GSH and H2O2 (Yin et al., 2019).”
BackgroundSelf‐Assembled Single‐Site Nanozyme for Tumor‐Specific Amplified Cascade Enzymatic Therapy
Wang, D., Wu, H., Wang, C., Gu, L., Chen, H., Jana, D., Feng, L., Liu, J., Wang, X., Xu, P., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202008868 · Cited by 275
Artificial Enzyme Catalyzed Cascade Reactions: Antitumor Immunotherapy Reinforced by NIR‐II Light
Wen, M., Ouyang, J., Wei, C., Li, H., Chen, W., & Liu, Y. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201909729 · Cited by 269 · cited 1×
“They also compared the catalytic rate of GSH reduction induced by single-atom Pd nanozyme, Cu2-xTe nanozyme, and copper hexacyanoferrate nanozyme (SSNEs) (Figure 1D), (Wen et al., 2019; Wang et al., 2021b) and first reported that Pd-based nanozyme can imitate GSH peroxidase with robust catalytic activity.”
BackgroundGlutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy
Ling, X., Tu, J., Wang, J., Shajii, A., Kong, N., Feng, C., Zhang, Y., Yu, M., Xie, T., Bharwani, Z., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b06400 · Cited by 263
Lin, L., Song, J., Song, L., Ke, K., Liu, Y., Zhou, Z., Shen, Z., Li, J., Yang, Z., Tang, W., et al. (2018) · Angewandte Chemie · doi:10.1002/ange.201712027 · Cited by 260
Metallodrugs in cancer nanomedicine
Peña, Q., Wang, A., Zaremba, O., Shi, Y., Scheeren, H. W., Metselaar, J. M., Kiessling, F., Pallares, R. M., Wuttke, S., & Lammers, T. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00468a · Cited by 259
Stimuli-Responsive Drug-Delivery Systems Based on Supramolecular Nanovalves
Li, Z., Song, N., & Yang, Y.-W. (2019) · Matter · doi:10.1016/j.matt.2019.05.019 · Cited by 256 · cited 1×
“Tumors have evolved a unique microenvironment, and typically display a more acidic condition, hypoxia, overexpressed reactive oxygen species (ROS), and glutathione (GSH) owing to their rapid proliferation and metabolism (Mura et al., 2013; Li et al., 2019).”
BackgroundWang, Z., Liu, B., Sun, Q., Feng, L., He, F., Yang, P., Gai, S., Quan, Z., & Lin, J. (2021) · ACS Nano · doi:10.1021/acsnano.1c04280 · Cited by 247 · cited 18×
“Considering the characteristics of the tumor environment, the GSH-scavenging strategy is indispensable to relieve the deficiency of •OH, thus prompting the effectiveness of CDT.”
BackgroundMethodInfluentialEmerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy
Yang, Y., Huang, J., Liu, M., Qiu, Y., Chen, Q., Zhao, T., Xiao, Z., Yang, Y., Jiang, Y., Huang, Q., et al. (2023) · Advanced Science · doi:10.1002/advs.202204365 · Cited by 242
Self-citationThe Coppery Age: Copper (Cu)‐Involved Nanotheranostics
Dong, C., Feng, W., Xu, W., Yu, L., Xiang, H., Chen, Y., & Zhou, J. (2020) · Advanced Science · doi:10.1002/advs.202001549 · Cited by 235 · cited 1×
“For example, copper ions can lead to GSH depletion through two mechanisms: the direct downregulation via the redox reaction between Cu and intracellular GSH, and the activation of a Fenton-like reaction by generating Cu to amplify oxidative stress (Dong et al., 2020).”
BackgroundStimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
Zhou, L., Wang, H., & Li, Y. (2018) · Theranostics · doi:10.7150/thno.22679 · Cited by 232 · cited 1×
“This stimuli-responsive behavior can be used for selective drug delivery into tumor tissue or cancer cells, thereby improving therapeutic efficiency and reducing side effects (Zhou et al., 2018; Peng et al., 2022).”
BackgroundEnhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem
Zhang, K., Meng, X., Yang, Z., Dong, H., & Zhang, X. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120278 · Cited by 232
Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management
Huo, D., Jiang, X., & Hu, Y. (2020) · Advanced Materials · doi:10.1002/adma.201904337 · Cited by 205 · cited 1×
“Nanotechnology especially has a prominent position in the area of biomedicine, and nanomedicines are being widely explored for the detection, diagnosis, and treatment of cancer (Yang et al., 2019; Huo et al., 2020).”
BackgroundNanoscale Coordination Polymers for Synergistic NO and Chemodynamic Therapy of Liver Cancer
Hu, Y., Lv, T., Ma, Y., Xu, J., Zhang, Y., Hou, Y., Huang, Z., & Ding, Y. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01093 · Cited by 204 · cited 1×
“designed nanoscale MOFs coordinated by GSH-sensitive NO donor (termed BPDB) and Fe, named Fe(II)BNCP (Figure 2F) (Hu et al., 2019).”
BackgroundWu, F., Du, Y., Yang, J., Shao, B., Mi, Z., Yao, Y., Cui, Y., He, F., Zhang, Y., & Yang, P. (2022) · ACS Nano · doi:10.1021/acsnano.1c06777 · Cited by 191 · cited 1×
“This GSH-responsive behavior not only caused contrast-enhanced magnetic resonance imaging, but also contributed to the tumor site-specific release of loaded therapeutic agents for realizing selective cancer therapy (Klochkov et al., 2021; Wu et al., 2022).”
BackgroundZhou, R., Wang, H., Yang, Y., Zhang, C., Dong, X., Du, J., Yan, L., Zhang, G., Gu, Z., & Zhao, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.016 · Cited by 178 · cited 2×
“…Gu et al. synthesized nanoclusters possessing multiple high Z elements, such as Fe3+ and W6+, to give them the ability of remarkable GSH exhaustion and amplified ROS generation upon radiation, both of which have been prevalently exploited as promising anticancer methods (Zhou et al., 2019).”
BackgroundNanoscale Metal–Organic Frameworks Generate Reactive Oxygen Species for Cancer Therapy
Ni, K., Lan, G., & Lin, W. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00397 · Cited by 163 · cited 1×
“The MOFs, assembled from metal ions and organic ligands via coordination bonds, have attracted growing interest in biomedical applications owing to their biocompatibility, biodegradability, adjustable structures, and diverse functions (Liang and Liang, 2020; Ni et al., 2020).”
BackgroundDeng, Y., Wang, Y., Jia, F., Liu, W., Zhou, D., Jin, Q., & Ji, J. (2021) · ACS Nano · doi:10.1021/acsnano.1c00698 · Cited by 160 · cited 1×
“developed supramolecular prodrug nanoassemblies (SPNA) for reactive nitrogen species (RNS)enhanced chemotherapy (Figure 3D) (Deng et al., 2021).”
BackgroundWu, Y., Guo, T., Qiu, Y., Lin, Y., Yao, Y., Lian, W., Lin, L., Song, J., & Yang, H. (2019) · Chemical Science · doi:10.1039/c9sc01070j · Cited by 151 · cited 1×
“Inspired by the unique characteristic of Se-based nanomaterials, the Te with the similar chemical properties to Se was developed for selective cancer therapy by Yang and co-workers (Wu et al., 2019).”
The glutathione system and the related thiol network in Caenorhabditis elegans
Ferguson, G., & Bridge, W. J. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101171 · Cited by 147 · cited 1×
“For example, several inorganic nanomaterials, including metal chalcogenide nanoparticles, hybrid metal nanoparticles, and single-atom metal nanoparticles, can act as GSH peroxidasemimicking nanozymes to exhaust intracellular GSH in cancer cells (Ferguson and Bridge, 2019; Chang et al., 2022).”
BackgroundQian, X., Han, X., Yu, L., Xu, T., & Chen, Y. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201907066 · Cited by 145 · cited 1×
“In addition, manganese oxide nanomaterials (MONs), including MnO2, Mn2O3, and Mn3O4, possess a similar GSH elimination property to Cu-based nanomaterials, and react with GSH along with the decomposition of MnOx into Mn 2+ for initiation of the Fenton-like reaction (Ding et al., 2020; Qian et al., 2020).”
BackgroundLabarrere, C. A., & Kassab, G. S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1007816 · Cited by 144 · cited 1×
“The overexpressed GSH, in the form of cellular free thiols, can generate highly reductive TME to resist DNA damage and protein homeostasis disorder, and protect tumor cells from programmed cell death (Labarrere and Kassab, 2022).”
BackgroundGarcía‐Giménez, J. L., Marković, J., Dasí, F., Queval, G., Schnaubelt, D., Foyer, C. H., & Pallardó, F. V. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.005 · Cited by 139 · cited 1×
“In terms of promoting tumor progression, studies showed that GSH can affect cell apoptosis by regulating the antiapoptotic protein of Bcl-2 family and Caspase activity (Luis Garcia-Gimenez et al., 2013).”
BackgroundWong, C. C., Qian, Y., Li, X., Xu, J., Kang, W., TONG, J. H. M., To, K., Ye, J., Li, W., Chen, H., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.011 · Cited by 138 · cited 1×
“Meanwhile, the gene level of matrix metallopeptidase nine and tumor necrosis factor α related to tumor metastasis exhibits a downward trend in SLC25A22-silenced cancer cells, indicating inhibition of GSH synthesis may play a critical role in the treatment of cancer metastasis (Wong et al., 2016).”
BackgroundNie, T., Zou, W., Meng, Z., Wang, L., Ying, T., Cai, X., Wu, J., Zheng, Y., & Hu, B. (2022) · Advanced Materials · doi:10.1002/adma.202206286 · Cited by 135 · cited 1×
“Several metal-based nanoparticles harboring multivalent elements, such as Cu/Cu, Mn/Mn, Mo/Mo, and Ir/Ir, possess strong oxidization, and can directly react with GSH (Cheng et al., 2021; Dong et al., 2021; Nie et al., 2022).”
BackgroundLiu, J., Wu, M., Pan, Y., Duan, Y., Dong, Z., Chao, Y., Liu, Z., & Liu, B. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201908865 · Cited by 132 · cited 5×
“Liu and co-workers developed a biodegradable nanoscale coordination polymer (termed Fe-DSCPPEG-cRGD), which was self-assembled from Fe3+ and cisplatin prodrug, and modified with PEG-cRGD (Liu et al., 2020).”
BackgroundInfluentialZhu, J., Xiao, T., Zhang, J., Che, H., Shi, Y., Shi, X., & van Hest, J. C. M. (2020) · ACS Nano · doi:10.1021/acsnano.0c03080 · Cited by 130
Wang, L., Yu, Y., Wei, D., Zhang, L., Zhang, X., Zhang, G., Ding, D., Xiao, H., & Zhang, D. (2021) · Advanced Materials · doi:10.1002/adma.202100599 · Cited by 129 · cited 18×
“Considering the characteristics of the tumor environment, the GSH-scavenging strategy is indispensable to relieve the deficiency of •OH, thus prompting the effectiveness of CDT.”
BackgroundMethodInfluentialRole of copper transporters in platinum resistance
Kilari, D. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i1.106 · Cited by 124 · cited 3×
“More interestingly, it was discovered that cisplatin-resistant cells manifested high levels of GSH, accompanied by accelerated accumulation of MRPs (Pearson and Cowan, 2021).”
BackgroundKong, H., Chu, Q., Fang, C., Cao, G., Han, G., & Li, X. (2021) · Advanced Science · doi:10.1002/advs.202100241 · Cited by 124 · cited 5×
“(B) Variations of GSH fluorescence intensity and 4T1 cells survival status after co-culture of CCF and 4T1 cells in different concentrations.”
BackgroundInfluentialWang, B., Dai, Y., Kong, Y., Du, W., Ni, H., Zhao, H., Sun, Z., Shen, Q., Li, M., & Fan, Q. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c14046 · Cited by 121
Biocatalytic Metal–Organic Frameworks: Prospects Beyond Bioprotective Porous Matrices
Liang, J., & Liang, K. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202001648 · Cited by 117 · cited 1×
“The MOFs, assembled from metal ions and organic ligands via coordination bonds, have attracted growing interest in biomedical applications owing to their biocompatibility, biodegradability, adjustable structures, and diverse functions (Liang and Liang, 2020; Ni et al., 2020).”
BackgroundZhang, X., Chen, X., Jiang, Y.-W., Ma, N., Xia, L.-Y., Cheng, X., Jia, H.-R., Liu, P., Gu, N., Chen, Z., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b00207 · Cited by 115 · cited 1×
“As a paradigm, Wu and co-workers integrated Au nanoclusters (Au NCs) with histidine to accomplish GSH exhaustive-prompted RT, denoted as Au NCs@His (Figure 7A) (Zhang et al., 2018).”
MethodSelf-citationTumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment
Wang, Y., Gao, F., Li, X., Niu, G., Yang, Y., Li, H., & Jiang, Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01278-z · Cited by 114 · cited 1×
“Nevertheless, excessive GSH is capable of neutralizing a great deal of ROS, which drastically weakens the metal-mediated Fenton reaction effect (Wang et al., 2022).”
BackgroundNew anti-cancer explorations based on metal ions
Hu, H., Xu, Q., Mo, Z., Hu, X., He, Q., Zhang, Z., & Xu, Z. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01661-w · Cited by 114 · cited 2×
“(IV) The metal nanomedicines show great potential for cancer therapy not only because of the capability of GSH exhaustion, but also for their wide range of other biological effects, such as interference with osmotic pressure, regulation of the immune system, and activation of biocatalysis (Hu et al., 2022).”
BackgroundImplications of nanotechnology for the treatment of cancer: Recent advances
Klochkov, S. G., Неганова, М. Е., Nikolenko, V. N., Chen, K., Somasundaram, S. G., Kirkland, C. E., & Aliev, G. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.028 · Cited by 111 · cited 2×
“Firstly, the synthesis of GSH-depleted multicomponent nanomedicines is so time-consuming that it still faces a huge technological gap from laboratory preparation to industrial production (Klochkov et al., 2021).”
BackgroundWang, D., Wu, H., Yang, G., Qian, C., Gu, L., Wang, H., Zhou, W., Liu, J., Wu, Y., Zhang, X., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c05499 · Cited by 109
Liang, K., Sun, H., Yang, Z., Yu, H., Shen, J., Wang, X., & Chen, H. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202100355 · Cited by 106 · cited 1×
“Meanwhile, several metal nanomedicines are capable of regulating intracellular GSH directly or indirectly, showing their potential in robust antitumor therapy (Zhang et al., 2020a; Liang et al., 2021; Zhao et al., 2022).”
BackgroundByun, S., Kim, S. W., Choi, H., Lee, C., & Lee, E. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05472.x · Cited by 105 · cited 1×
“Recently, exhaustion of GSH in cisplatin-resistant cells has been extensively utilized to strengthen the cytotoxicity of cisplatin and sensitize chemotherapy (Byun et al., 2005).”
BackgroundProtection against Radiotherapy-Induced Toxicity
Hall, S., Rudrawar, S., Zunk, M., Bernaitis, N., Arora, D., McDermott, C., & Anoopkumar-Dukie, S. (2016) · Antioxidants · doi:10.3390/antiox5030022 · Cited by 102 · cited 1×
“Indirect damage, accounting for two-thirds of the radiation-induced cell injury, means ionizing radiation is able to react with substances in cells such as water to form toxic ROS (Hall et al., 2016).”
BackgroundYang, X., Xu, X. M., Wang, M., Xu, H., Peng, X., Han, N., Yu, T., Li, L., Li, Q., Chen, X., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01455-0 · Cited by 92
Chemotherapy-enabled/augmented cascade catalytic tumor-oxidative nanotherapy
Xiang, H., You, C., Liu, W., Wang, D., Chen, Y., & Dong, C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121071 · Cited by 87 · cited 2×
“designed a Pt (IV)-based responsive nanoreactor modified by Cu-based MOF (termed CuMOF@Pt (IV)) for enhanced chemotherapy via depleting GSH (Xiang et al., 2021).”
MethodZhang, M., Guo, X., Wang, M., & Liu, K. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.026 · Cited by 84 · cited 2×
“Meanwhile, several metal nanomedicines are capable of regulating intracellular GSH directly or indirectly, showing their potential in robust antitumor therapy (Zhang et al., 2020a; Liang et al., 2021; Zhao et al., 2022).”
BackgroundDuan, H., Guo, H., Zhang, R., Wang, F., Liu, Z., Ge, M., Yu, L., Lin, H., & Chen, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120206 · Cited by 78 · cited 2×
“In another case, a two-dimensional (2D) composite nanoagent was prepared by Lin et al. for endogenous and exogenous synergetic cancer therapy (Figure 7G) (Duan et al., 2020).”
BackgroundMethodMultifunctional platinum‐based nanoparticles for biomedical applications
Cheng, Q., & Liu, Y. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1410 · Cited by 76 · cited 1×
“This complex can then be cleared by MRPs (Kilari et al., 2016; Cheng and Liu, 2017).”
BackgroundFranco, R., DeHaven, W. I., Sifre, M. I., Bortner, C. D., & Cidlowski, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807061200 · Cited by 75 · cited 1×
“The overexpressed GSH endows cancer cells with the capacity to modulate the redox homeostasis and prevents cancer cells from undergoing apoptosis (Franco et al., 2008).”
BackgroundWang, C., Cao, F., Ruan, Y., Jia, X., Zhen, W., & Jiang, X. (2019) · Angewandte Chemie · doi:10.1002/ange.201903981 · Cited by 74 · cited 1×
“prospective nanophotosensitizers, such as Fe-TCPP, Mn-TCPP, and Cu-TCPP, which could be decomposed in overproduced GSH conditions, leading to intracellular GSH elimination (Wan et al., 2019; Wang et al., 2019; Wang et al., 2020a).”
BackgroundZhao, R., Zhu, Y., Zhou, J., Liu, B., Du, Y., Gai, S., Shen, R., Feng, L., & Yang, P. (2022) · ACS Nano · doi:10.1021/acsnano.2c03222 · Cited by 64 · cited 2×
“designed manganesedoped VSe2 nanosheets for hyperthermia-assisted tumor therapy by dual depleting the GSH (Zhao et al., 2022).”
BackgroundMethodModulating intracellular oxidative stress via engineered nanotherapeutics
Hu, J., & Liu, S. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.040 · Cited by 61 · cited 1×
“In general, elevated GSH can be observed in many cancers, including lung cancer, ovarian cancer, breast cancer, and head-neck cancer, and this adaptive upregulation of GSH has various effects on tumor advancement, metastasis, and drug resistance (Hu and Liu, 2020).”
BackgroundGlutathione-coordinated metal complexes as substrates for cellular transporters
Pearson, S. A., & Cowan, J. A. (2021) · Metallomics · doi:10.1093/mtomcs/mfab015 · Cited by 61 · cited 3×
“More interestingly, it was discovered that cisplatin-resistant cells manifested high levels of GSH, accompanied by accelerated accumulation of MRPs (Pearson and Cowan, 2021).”
BackgroundGlutathione in metastases: From mechanisms to clinical applications
Estrela, J. M., Ortega, Á., Mena, S., Sirerol, J. A., & Obrador, E. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1136259 · Cited by 56 · cited 1×
“For instance, GSH, composed of cysteine, glycine, and glutamic acid, accounts for the majority of cellular antioxidants to create highly reductive TME and is involved in tumor initiation, progression, and metastasis (Harris et al., 2015; Estrela et al., 2016).”
BackgroundHarris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.01.009 · Cited by 52
Self‐Assembled Single‐Site Nanozyme for Tumor‐Specific Amplified Cascade Enzymatic Therapy
Wang, D., Wu, H., Wang, C., Gu, L., Chen, H., Jana, D., Feng, L., Liu, J., Wang, X., Xu, P., et al. (2020) · Angewandte Chemie · doi:10.1002/ange.202008868 · Cited by 51
Zhou, R., Yan, L., Dong, X., Zhu, S., Chen, K., Wu, Y., Xiang, H., Li, L., Zhang, G., Gu, Z., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101003 · Cited by 43 · cited 1×
“The moderately acidic environment can trigger Fe4Se2W18 NCs to release Fe , which can be reduced by GSH to produce Fe along with the decomposition of H2O2 for •OH production, rendering cancer cells more susceptible to oxidative stress (Zhou et al., 2021).”
BackgroundSingle‐Atom Pd Nanozyme for Ferroptosis‐Boosted Mild‐Temperature Photothermal Therapy
Chang, M., Hou, Z., Wang, M., Yang, C., Wang, R., Li, F., Liu, D., Peng, T., Li, C., & Lin, J. (2021) · Angewandte Chemie · doi:10.1002/ange.202101924 · Cited by 43
Kuermanbayi, S., Yang, Y., Zhao, Y., Li, Y., Wang, L., Yang, J., Zhou, Y., Xu, F., & Li, F. (2022) · Chemical Science · doi:10.1039/d2sc02708a · Cited by 30 · cited 1×
“GSH could detoxify heterogeneous substances under the catalysis of Glutathione S-transferases (GST), then secrete them via the multidrug resistance associated proteins (MRPs) efflux pump (Kuermanbayi et al., 2022).”
BackgroundArtificial Enzyme Catalyzed Cascade Reactions: Antitumor Immunotherapy Reinforced by NIR‐II Light
Wen, M., Ouyang, J., Wei, C., Li, H., Chen, W., & Liu, Y. (2019) · Angewandte Chemie · doi:10.1002/ange.201909729 · Cited by 29
Tumor Microenvironment Responsive Single‐Atom Nanozymes for Enhanced Antitumor Therapy
Chang, M., Hou, Z., Wang, M., Li, C., Kheraif, A. A. A., & Lin, J. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202104081 · Cited by 28 · cited 1×
“For example, several inorganic nanomaterials, including metal chalcogenide nanoparticles, hybrid metal nanoparticles, and single-atom metal nanoparticles, can act as GSH peroxidasemimicking nanozymes to exhaust intracellular GSH in cancer cells (Ferguson and Bridge, 2019; Chang et al., 2022).”
Background
Cited by
New-generation advanced PROTACs as potential therapeutic agents in cancer therapy
Wang, C., Zhang, Y., Chen, W., Wu, Y., & Xing, D. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02024-9 · Cited by 188
“This strategy takes advantage of the unique characteristics of tumor cells, such as their increased levels of GSH [86–89].”
BackgroundTumor microenvironment responsive nanozymes for multimodal imaging of tumors
Wang, H., Ouyang, W., & Liu, H. (2024) · Nano TransMed · doi:10.1016/j.ntm.2024.100032 · Cited by 67
Roy, N., & Paira, P. (2024) · ACS Omega · doi:10.1021/acsomega.3c08890 · Cited by 63
“Two enzymatic steps are involved in the consumption of one molecule of ATP for each catalytic cycle, where ATP breaks down into adenosine monophosphate (ADP) and Pi, providing energy for the transportation of amino acids and the synthesis of GSH. 72 − 75 It can be highlighted that synthesis of GSH is governed by three…”
BackgroundInfluentialEmerging trends, and prospects in Nanozyme engineering to enhance dual-mode sensing applications
Singh, R., Sharma, A., Banik, O., Navyatha, B., Santhosh, C., Banoth, E., Balaji, R., Chandrasekar, N., Kumar, S., & Daima, H. K. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216768 · Cited by 54
Nanosensitizer-assisted sonodynamic therapy for breast cancer
Yu, J., Hu, J.-R., Tian, Y., Lei, Y.-M., Hu, H.-M., Lei, B.-S., Zhang, G., Sun, Y., & Ye, H.-R. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03311-3 · Cited by 43
“Hypoxia and high GSH concentrations in the TME make tumors resistant to SDT therapy [61–63].”
Metadata
- Authors
- Liu, P., Hao, L., Liu, M., & Hu, S.
- Affiliations
- Central South University (CN)
- Corresponding author
- Liu, Min
- Hu, Shuo
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2023-03-10
- Volume
- 11
- Pages
- 1161472-1161472
- ISSN
- 2296-4185 (ISSN-L)
- PMC
- PMC10036587
- OpenAlex
- W4323857505
- Cited by
- 58
- References
- 95
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 17 · 2023: 2
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Bioengineering and Biotechnology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Science and Technology Program of Hunan Province
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Materials Chemistry › Advanced Nanomaterials in Catalysis
- Keywords
- glutathione depletion, synergistic cancer therapy, metal-organic frameworks, photodynamic therapy, sonodynamic therapy, chemodynamic therapy, ferroptosis, radiotherapy, reactive oxygen species, chemotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.